Filing Flows › Medpace Holdings (MEDP) › Capital expenditures
Medpace Holdings (MEDP) capital expenditures by quarter
Medpace Holdings' capital expenditures were $20.2M in Q3 2026 (third quarter 2026), -16% from Q2 2026. Over the last 7 quarters it ranged from $4.5M (Q4 2025) to $23.9M (Q2 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $20.2M | -16% | +88% |
| Q2 2026 | $23.9M | +251% | +291% |
| Q1 2026 | $6.8M | +50% | -32% |
| Q4 2025 | $4.5M | -58% | — |
| Q3 2025 | $10.7M | +75% | — |
| Q2 2025 | $6.1M | -39% | — |
| Q1 2025 | $10.0M | — | — |
Q3 2026 at a glance
Medpace Holdings, Q3 2026: revenue $716M (+8% year over year), operating margin 23.1%, net earnings $137M, operating cash flow $217M. The chart follows the revenue to costs, profit and cash.
Questions
What is Medpace Holdings' capital expenditures?
Medpace Holdings' capital expenditures were $20.2M in Q3 2026 (third quarter 2026), -16% from Q2 2026.
How has Medpace Holdings' capital expenditures changed?
Over the last 7 quarters it ranged from $4.5M (Q4 2025) to $23.9M (Q2 2026).